Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Hypocomplementemic Urticarial Vasculitis Syndrome

What Causes HUVS? What Triggers Vasculitis Flares?

At a Glance

HUVS often has no single identifiable cause. It reflects immune-system inflammation in small blood vessels and may be associated with lupus or follow certain infections, medicines, or vaccines, but timing alone does not prove that an exposure caused a flare.

It is completely natural to wonder why you developed hypocomplementemic urticarial vasculitis (HUVS) and whether something you did—or something in your environment—caused it. The most important thing to know is that HUVS is a complex immune system condition, and it is not something you caused through your lifestyle choices or daily habits. In many people, doctors cannot identify a single specific reason the condition began [1].

Unlike ordinary hives, the hives in urticarial vasculitis typically last longer than 24 hours, may burn or hurt rather than just itch, and can leave faint bruising or discoloration behind [2]. HUVS is known to be driven by inflammation in your small blood vessels, and research has identified several underlying conditions, infections, and medications that can be associated with the disease or trigger flares [3].

How the Inflammation Happens

HUVS is classified as an immune-complex small-vessel vasculitis [4]. In a healthy immune system, antibodies bind to targets (called antigens), such as viruses or bacteria, to help clear them from the body. In HUVS, antibodies bind to antigens—which can sometimes be the body’s own proteins—to form clusters called immune complexes [4]. Many patients with HUVS also develop specific autoantibodies, called anti-C1q antibodies, which further support the diagnosis [5].

These immune complexes get trapped in the walls of small blood vessels and activate a group of immune proteins called complement [6]. This activation consumes your complement proteins (which is why blood levels drop, or become “hypocomplementemic”) and signals inflammatory cells to attack the blood vessel walls. This vessel injury causes the characteristic hives, pain, and systemic symptoms (symptoms that affect the whole body) [6][5].

Primary HUVS (Uncertain Cause)

For many patients, HUVS is considered “primary” or idiopathic, meaning no underlying disease or single initiating cause is clearly identified [1][7]. The immune system simply becomes overactive and begins the inflammatory process. While having an uncertain cause can be frustrating, it does not prevent your medical team from treating the inflammation directly.

Associated Conditions and Potential Triggers

Even when HUVS appears to be the primary issue, doctors will typically look for potential triggers or associated conditions, as addressing these can sometimes help manage the vasculitis [8].

Systemic Autoimmune Conditions

HUVS has a strong association with other systemic autoimmune diseases, most notably systemic lupus erythematosus (SLE), commonly known as lupus [7][1]. Because the two conditions share many clinical features—including low complement levels, joint pain, and kidney involvement—they can be difficult to tell apart, and they sometimes overlap [7][3].

Your doctor will likely run specific blood tests (such as ANA and anti-dsDNA) and urine tests (urinalysis) to check if your HUVS is occurring alongside lupus [9]. It is important to know that a positive ANA blood test alone does not mean you have lupus; doctors look at the whole clinical picture, including your symptoms, kidney function, and complement patterns [7]. Other autoimmune conditions, such as Sjögren’s disease, have also been reported in association with HUVS, though much less frequently [10].

Infections

Certain infections have been reported to happen around the same time as the onset of HUVS or its flares (a period of worsening symptoms). Documented viral and bacterial associations in the medical literature include hepatitis B and C, infectious mononucleosis (Epstein-Barr virus), influenza, COVID-19, Mycoplasma, and Lyme disease [11][12][13].

However, many of these links are based on single case reports or apply to urticarial vasculitis in general, rather than HUVS specifically [11][14]. A temporal association (happening at the same time) does not prove that the infection directly caused the vasculitis [11][12]. Therefore, testing for infections is not a “one size fits all” process; your doctor will order tests based on your specific exposures, risks, and symptoms.

Medications and Vaccines

In rare instances, medications or vaccines can trigger urticarial vasculitis [1][8][15]. A variety of drugs have been reported in case studies as potential triggers, including certain antibiotics, analgesics (pain medicines), blood pressure medications, and specific therapies used to treat other autoimmune diseases [16][17]. There are also uncommon case reports of vasculitis flares occurring shortly after vaccinations [15].

If a medication is suspected to be a true trigger, a clinician may stop or substitute the drug. However, improvement can take time, and some people may still need treatment for the vasculitis even after the trigger is removed [8][16].

Crucial Warning: You should never stop taking a prescribed medication or avoid recommended vaccines on your own without consulting your doctor. Stopping medications suddenly can be dangerous, and timing alone does not prove a medication or vaccine caused your symptoms. Instead, work with your care team to carefully review your timeline of medications, supplements, vaccines, and recent illnesses.

When to Seek Urgent Care

Because HUVS can affect internal organs like the kidneys, lungs, and gastrointestinal tract, monitoring for new symptoms is critical [18][19].

Seek immediate medical attention if you experience:

  • Severe difficulty breathing or new shortness of breath
  • Coughing up blood or severe chest pain
  • Severe abdominal pain or bloody stool
  • Very dark, “cola-colored,” or foamy urine
  • Markedly reduced urine output
  • Rapidly worsening swelling in your legs or face

Prompt evaluation of these symptoms ensures that any organ involvement is treated early to prevent long-term damage [20][18].

Common questions in this guide

Why did I develop HUVS if no trigger can be found?
Many people with HUVS have no single identifiable underlying disease or starting event; doctors may call this primary or idiopathic HUVS. The condition is linked to an overactive immune response and is not caused by ordinary lifestyle choices or daily habits.
Is HUVS related to lupus or other autoimmune diseases?
HUVS is strongly associated with systemic lupus erythematosus, or lupus, and the conditions can sometimes overlap. Doctors may consider symptoms, complement-protein levels, ANA and anti-dsDNA blood tests, urine testing, and kidney function; a positive ANA alone does not establish lupus.
What infections have been reported before an HUVS flare?
Reports have described urticarial vasculitis around the time of hepatitis B or C, Epstein-Barr virus infection, influenza, COVID-19, Mycoplasma, and Lyme disease. These reports do not prove that an infection caused HUVS, so testing is chosen based on your symptoms, risks, and exposures.
Can a medication or vaccine trigger an HUVS flare?
Rare reports describe flares after certain antibiotics, pain medicines, blood pressure medicines, autoimmune treatments, or vaccines. Do not stop a prescription or avoid a recommended vaccine on your own; a clinician should review the timing and decide whether a medication should be changed.
Which HUVS symptoms require immediate medical attention?
Seek immediate care for severe breathing difficulty, coughing up blood, severe chest or abdominal pain, bloody stool, cola-colored or foamy urine, much less urine, or rapidly worsening swelling of the legs or face. These symptoms can signal involvement of the lungs, digestive tract, or kidneys and need prompt evaluation.
How can I track possible HUVS flare triggers?
Keep a dated record of hives, joint pain, breathing changes, recent illnesses, medicines and supplements, and vaccines. Share the timeline with your clinician because symptoms occurring after an exposure do not by themselves prove that exposure caused the flare.

Get notified when new evidence is published on Hypocomplementemic urticarial vasculitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    A case report of hypocomplementemic urticarial vasculitis presenting with membranoproliferative glomerulonephritis.

    Vallianou K, Skalioti C, Liapis G, et al.

    BMC nephrology 2020; (21(1)):351 doi:10.1186/s12882-020-02001-6.

    PMID: 32811472
  2. 2

    Urticarial vasculitis.

    Gu SL, Jorizzo JL

    International journal of women's dermatology 2021; (7(3)):290-297 doi:10.1016/j.ijwd.2021.01.021.

    PMID: 34222586
  3. 3

    Correct approach in urticarial vasculitis made early diagnosis of lupus nephritis possible: a case report.

    Smets K, Van Baelen A, Sprangers B, De Haes P

    Journal of medical case reports 2022; (16(1)):314 doi:10.1186/s13256-022-03477-6.

    PMID: 35989318
  4. 4

    Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis.

    Marzano AV, Maronese CA, Genovese G, et al.

    The Journal of allergy and clinical immunology 2022; (149(4)):1137-1149 doi:10.1016/j.jaci.2022.02.007.

    PMID: 35396080
  5. 5

    [Hypocomplementemic urticarial vasculitis].

    Jachiet M, Flageul B, Bouaziz JD, et al.

    La Revue de medecine interne 2018; (39(2)):90-98 doi:10.1016/j.revmed.2017.03.005.

    PMID: 28457680
  6. 6

    Case Report: Hypocomplementemic urticarial vasculitis syndrome in a pediatric patient with complement factor 1 deficiency.

    Lin S, Kafisheh D, Elder ME

    Frontiers in pediatrics 2024; (12()):1448094 doi:10.3389/fped.2024.1448094.

    PMID: 39376673
  7. 7

    Urticarial hypocomplementemic vasculitis syndrome and systemic lupus erythematosus: a case report and review of the literature.

    Ouerdani Y, Ben Achour T, Ben Hmid A, et al.

    Frontiers in immunology 2025; (16()):1649699 doi:10.3389/fimmu.2025.1649699.

    PMID: 40852710
  8. 8

    Treatment of urticarial vasculitis: A systematic review.

    Kolkhir P, Grakhova M, Bonnekoh H, et al.

    The Journal of allergy and clinical immunology 2019; (143(2)):458-466 doi:10.1016/j.jaci.2018.09.007.

    PMID: 30268388
  9. 9

    Hypocomplementemic Urticarial Vasculitis: A Case Report.

    Aparicio EE, Guerrero DV, Alcántara VD, et al.

    Cureus 2025; (17(12)):e100143 doi:10.7759/cureus.100143.

    PMID: 41589185
  10. 10

    Hypocomplementemic urticarial vasculitis: a rare presentation revealing systemic lupus erythematosus and Sjögren's disease.

    Taharboucht S, Mehiris C, Bellil S, et al.

    Reumatismo 2026; (78(2)) doi:10.4081/reumatismo.2026.1930.

    PMID: 42274075
  11. 11

    Exceptional association of hypocomplementemic urticarial vasculitis syndrome (HUVS) and symptomatic pulmonary histoplasmosis: a case-based literature review.

    Alomari M, Al Momani L, Khazaaleh S, et al.

    Clinical rheumatology 2019; (38(6)):1691-1697 doi:10.1007/s10067-019-04548-8.

    PMID: 30980192
  12. 12

    Hypocomplementemic Urticarial Vasculitis Syndrome with Membranous Nephropathy: Case Report.

    Jung SW, Choi YY, Choi IS, et al.

    Journal of Korean medical science 2017; (32(12)):2064-2068 doi:10.3346/jkms.2017.32.12.2064.

    PMID: 29115092
  13. 13

    Urticarial vasculitis.

    Ergun T

    Current opinion in rheumatology 2025; (37(1)):45-50 doi:10.1097/BOR.0000000000001058.

    PMID: 39600289
  14. 14

    Normocomplementemic Urticarial Vasculitis Associated with A/H1N1 in a Child. Case Report.

    Gökçe Ş, Dörtkardeşler BE, Aslan A

    SN comprehensive clinical medicine 2020; (2(12)):2962-2964 doi:10.1007/s42399-020-00661-x.

    PMID: 33263100
  15. 15

    Normocomplementemic Urticarial Vasculitis Following Influenza Vaccination: A Case Report and Review of the Literature.

    Mima Y, Ohtsuka T, Ebato I, et al.

    International medical case reports journal 2024; (17()):823-829 doi:10.2147/IMCRJ.S483023.

    PMID: 39359663
  16. 16

    Development of hypocomplementemic urticarial vasculitis during certolizumab pegol treatment for rheumatoid arthritis: A case report.

    Horai Y, Ishikawa H, Iwanaga N, et al.

    Journal of clinical pharmacy and therapeutics 2020; (45(5)):1179-1182 doi:10.1111/jcpt.13117.

    PMID: 31990069
  17. 17

    Clinical characteristics and treatment outcomes in patients with urticarial vasculitis.

    Serarslan G, Okyay E

    Northern clinics of Istanbul 2021; (8(5)):513-517 doi:10.14744/nci.2020.55476.

    PMID: 34909591
  18. 18

    [Hypocomplementemic urticarial vasculitis syndrome: a rare but not always benign condition].

    Sjöwall C, Skattum L, Olsson M, et al.

    Lakartidningen 2019; (116()).

    PMID: 31794046
  19. 19

    Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis).

    Sjöwall C, Mandl T, Skattum L, et al.

    Rheumatology (Oxford, England) 2018; (57(8)):1400-1407 doi:10.1093/rheumatology/key110.

    PMID: 29718374
  20. 20

    Hypocomplementemic Urticarial Vasculitis Syndrome: A Rare Form of Vasculitis.

    Singh SK, Gupta M, Rani S, Singh P

    Cureus 2025; (17(1)):e78227 doi:10.7759/cureus.78227.

    PMID: 40026936

This page is for informational purposes only and does not constitute medical advice about HUVS. Do not stop prescribed medicines or skip recommended vaccines without discussing possible triggers and symptoms with your clinician.